Adverse Events with D-penicillamine Therapy in Hepatic Wilson's Disease: A Single-Center Retrospective Audit.

Sanjay KumarBiswa Ranjan PatraMohammed IrtazaPraveen Kumar RaoSuprabhat GiriHarish DarakAmrit GopanAditya KaleAkash Shukla

Published in: Clinical drug investigation (2022)

D-penicillamine treatment is associated with significant AEs mainly related to blood, kidney, and skin. Temporary cessation of drug with reintroduction at a lower dose is an effective and safe option.

Keyphrases

cross sectional
soft tissue
emergency department
wound healing
mesenchymal stem cells